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ABSTRACT
Bovine viral diarrhea virus (BVDV) genomic RNA was identified as a 12.5-kb single-stranded RNA molecule in
both infected bovine embryonic kidney cells (BEK-1) and partially purified virions. BVD virion RNA was par-
tially purified and used as a template for cDNA synthesis. BVDV-specific cDNA sequences were molecularly
cloned and shown to hybridize to infected cell RNA but not to uninfected cell RNA orDNA. A single RNA species
of 12.5 kb, representing the viral RNA genome, was detected in infected cells. A preliminary map of the BVDV
specific cDNA clones was constructed and five major, nonoverlapping families were observed, accounting for
approximately one-half of the viral genome.
INTRODUCTION
Bovine viral diarrhea virus (BVDV) is a non-arthropod-borne Togavirus belonging to the pestivirus genus. The
virus causes an economically important disease in cattle of
worldwide distribution, associated with an enteric and/or
respiratory syndrome, especially in calves, and character-
ized by lesions of the mucous membranes in the digestive
and respiratory tracts. Abortion, stillbirth, and/or congenital
birth defects are commonly attributed to infection of preg-
nant cows.
Limited and partially contradictory information is avail-
able concerning the genetic and physical structure of the vi-
ral RNA, perhaps due to difficulties associated with in vitro
generation of adequate material for analysis. Early studies
reported a single-stranded RNA genome of positive polarity
of 9-12 kb (for review, see Horzinek, 1981), while a more
recent study determined that the prevalent RNA species in
BVDV-infected cells was 8.2 kb (Purchio et al., 1983).
During the present work we defined a new cell-virus
strain pair, the use of which permits routine in vitro produc-
tion of high titre progeny virus in amounts suitable for
biochemical manipulations. In this study we describe the
identification of a 12.5-kb viral RNA species, its partial pu-
rification, and initial molecular characterization. Using viral
RNA as a template for reverse transcription, 95 recombinant
DNA plasmids carrying BVDV-specific information were




Bovine embryonic kidney cells (BEK-1) were grown in
MEM (Earl's) containing 0.85 g/liter NaHCOj and 10% y-
irradiated fetal calf serum. The biologically cloned Osloss
strain of BVDV was obtained from RIT, Belgium.
Virus production
Virus was amplified from stocks through four passages of
increasing size on BEK-1 cells at a multiplicity of infection
of 0.1. For a typical virus production experiment, 150
plastic flasks (175 cm2) of freshly confluent BEK-1 cells
were used for a fifth and last passage. The cells were washed
three times with infection buffer (MEM [Earl's] containing
2.2 g/liter ofNaHC03 pH 7.6) and then infected with 2 ml of
medium containing BVDV at a multiplicity of infection of
0.5 pfu/cell. After 1 hr at 35CC, 18 ml of medium were added
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and the cells were incubated for 4-5 days at 35°C.
Cytopathic effects (CPE), as evidenced by vacuolation
followed by cell lysis, was consistently 80%, usually
5^90%. The infected cell medium (about 3 liters) was
collected and stored at 4°C. The remaining cells were
harvested by scraping in 2 ml of infection buffer per flask,
subjected to three cycles of freezing and thawing, and the
final suspension was added to the collected infected cell me-
dium. Yields of virus were consistently s^lO7 pfu/ml while
our best preparations gave titers of 108 pfu/ml. After centri-
fugation at 10,000 x g for 30 min, the supernatant was con-
centrated tenfold by ultrafiltration on a millipore PTHK
10,000 membrane and the virus was collected by ultracen-
trifugation at 100,000 x g for 4.5 hr at 4°C.
Extraction and purification of viral RNA
Total RNA was isolated from the virus pellet by the CsCl/
guanidinium thiocyanate method (Chirgwin et ai, 1979)
and stored in 70% ethanol at -20°C.
To separate high-molecular-weight viral RNA from con-
taminating cellular RNAs in the preparation, and aliquot
containing approximately 5u.g of total RNA was centrifuged
at 10,000 x g for 15 min at 4°C. The pellet was washed with
80% ethanol, denatured by incubation in 375 u.1 of 99%
dimethylsulfoxide, 5 mM Tris-HCl pH 7.5 for 5 min at
37°C. After addition of 1.125 ml of 5 mM Tris-HC 1 pH 7.5,
1 mM EDTA, and 1% Sarkosyl, the solution was heated for
2 min at 70°C and quickly cooled on ice. This solution was
distributed onto five 15-30% linear sucrose gradients in 5
mM Tris-HCl pH 7.5, 10 mM EDTA, 0.1 M NaCl, 1%
Sarkosyl prepared in sterile, siliconized Beckman SW41
tubes. A sixth gradient was similarly loaded with an aliquot
of the same RNA previously 3'-labeled (see below) for use
as a marker. After centrifugation for 16 hr at 19,000 rpm
(20°C) in a Spinco SW41 rotor, the gradients were collected
(1 ml fractions), and the RNA from each fraction of marker
gradients was subjected to formaldehyde agarose gel elec-
trophoresis to detect those fractions containing high-
molecular-weight BVDV-specific RNA. Fractions from the
five sample gradients equivalent to those containing labeled
marker RNA were separately precipitated with 2.5 volumes
of ethanol in the presence of carrier yeast RNA (10u,g).
Intraceilular RNA labeling
BEK-1 cells grown in 75-cm2 plasstic flasks were washed
3 times with infection buffer and infected with BVDV at
multiplicities of infection of 50-100 pfu/cell in 1 ml of infec-
tion buffer. After 1 hr at 35°C, an additional 4 ml of infection
buffer was added and the incubation continued. At selected
intervals 100 u.Ci aliquots of [3H]uridine (30-40 Ci/mmol,
Amersham) were added and after 30 min of incorporation,
cellular RNA was extracted by the CsCl/guanidinium thio-
cyanate method (Chirgwin etai, 1979). The resultant pellet
of RNA, obtained after ultracentrifugation through a 5.7 M
CsCl cushion, was directly analyzed by formaldehyde agar-
ose gel electrophoresis. After the gel was dried bands were
seen by fluorography and autoradiography.
In vitro RNA labeling
Labeling of RNA (3' terminus) with [32P]PCP(Amersham)
using T4 RNA ligase (P-L Biochemicals) was performed as
described by England et ai, (1980). To polyadenylate RNA
in vitro, the method of Sippel (1973) was used with some
modifications. An amount of of purified BVDV RNA esti-
mated to be 0.7 p.g was incubated in 5 u.1 of 5 mM methyl-
mercury hydroxide for 10 min at room temperature. Follow-
ing denaturation, the sample was incubated for 6 min at 37CC
with 20 units of poly(A) polymerase (BRL) and 500 u.Ci of
[3H]ATP (36 Ci/mmol, Amersham) in 50 p.1 of 50 mM Tris-
HCl pH 7.5, 10 mM MgCl2, 2.5 mM MnCl2, 0.3 M NaCl,
1.5 mM 2-mercaptoethanol, containing 2.5 u.g of RNase free
bovine serum albumin (BSA) and 5 units of human placenta!
ribonuclease inhibitor (BRL). (BSA was made RNAse-free
by chromatography on UMP-agarose [Maniatis et ai, 1982].)
The sample was then deproteinized with phenol/chloroform
and the RNA purified by chromatography on Sephadex G50
followed by precipitation with 2.5 volumes of ethanol.
Synthesis of labeled cDNA probes
One microgram of partially purified BVDV genomic
RNA was initially incubated for 10 min at room temperature
in 5 u.1 of 10 mMmethylmercury hydroxide and then an addi-
tional 45 min at 37°C with 40 units of AMV reverse tran-
scriptase (Life Sciences) in 100 p.1 of 50 mM Tris-HCl pH
8.3, 10 mM MgCl2, 1.5 mM 2-mercaptoethanol, 1 mM
dATP, dGTP, and dTTP, 10 \iM dCTP ,0.2 mg/ml of actino-
mycin D, containing 5 units of human placental ribonuclease
inhibitor, 500 u.Ci of [a32P]dCTP (3000 Ci/mmol, Amersham)
and 20 p,g of calf thymus DNA random primers (prepared as
described by Maniatis et ai, 1982). At 15 and 30 min of
incubation, an additional 10 units of reverse transcriptase
were added. At the end of the reaction period, the sample
was deproteinized with phenol/chloroform and the labeled
cDNA purified by chromatography on a Sephadex G50 col-
umn. RNA was hydrolyzed with 0.1 M NaOH (1 hr at 65°C)
and the cDNA sample then neutralized with 0.1 M acetic
acid and added directly to hybridization buffer.
Synthesis of cDNA for cloning
Approximately 1 u.g of BVDV-specific RNA (partially
purified viral genome) was incubated (10 min, room temper-
ature) with 10 mM methylmercury hydroxide in a volume of
10 u.1 and the excess methylmercury hydroxide then titrated
by addition of 1 p.1 of a 3 M ß-mercaptoethanol solution. The
denatured RNA sample was used immediately for the syn-
thesis of cDNA by incubation at 37°C in the presence of 50
mM Tris-HCl pH 8.0, 1 mM dATP, dCTP, dGTP, and
dTTP, 2.5 u,g/ml dT12.)8, 10 mMMgCl2, 10 u,g/ml actino-
mycin D, containing 100 units of placental ribonuclease in-
hibitor and 60 units of reverse transcriptase in a total volume
of 100 u.1.
At the end of the reaction (45 min), the sample was diluted
to 400 u.1 with a buffer containing 10 mM Tris-HCl pH 7.0,
100 mM NaCl, 10 mM EDTA, and 0.2% NaDodS04. After
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The resultant mixture of RNA and RNAxDNA hybrids
was treated sequentially with pancreatic ribonuclease A and
nuclease Si as follows. The sample (10 p.1) was diluted into
50 u,l buffer S, (50 mMNa acetate pH 4.5, 500 mM NaCl, 1
mM ZnCl2) and digested for 15 min at room temperature
with 20 units of S, nuclease (Sigma). The reaction was
stopped by diluting the sample to 500 u.1 with a buffer con-
taining 50 mM Tris-HCl pH 7.0, 50 mM NaCl, and 10 mM
EDTA. RNase A was added to a final concentration of 20
u-g/ml and digestion was continued for 15 min at room tem-
perature. After phenol/chloroform extraction, the RNAxDNA
hybrids were concentrated by ethanol precipitation and
fractionated on a Sepharose CL4B column prepared in a 1-
ml plastic pipette. The fractions containing the excluded ma-
terial (cDNA:RNA hybrid molecules greater than 800bp in
length) were then pooled and ethanol precipitated.
Tailing of cDNA.RNA hybrids
and cloning into Escherichia HB101
The final recovery of RNAxDNA hybrid in the excluded
fraction for the above dT-primed reaction was approximate-
ly 50 ng. This material was then tailed with dC residues
under conditions yielding 15-25 residues per DNA or RNA
terminus (Maniatis et ai, 1982) and inserted into a pBR322
vector linearized at the Pst I site and tailed with dG (NEN).
After annealing of the above RNAxDNA hybrid preparation
at a vector DNA concentration of 0.1 u.g/ml, the samples
were used to tranform E. coli HB101 under standard con-
ditions.
Preparation of labeled inserts
Recombinant plasmids were isolated in alkaline NaDod-
S04 (Maniatis et ai, 1982) and digested with Pst I and the
resultant inserts were purified on 5% polyacrylamide gels.
One microgram of each insert was then further digested with
Dde I and Mbo I and labeled by end-filling using the Klenow
fragment of DNA polymerase I and the four [a-32P]dNTPs
(3,000Ci/mmol, Amersham). (The restriction enzymes em-
ployed were obtained from New England Biolabs.)
Gel electrophoresis and hybridizations
RNA agarose gel electrophoresis in the presence of 2.2 M
formaldehyde was carried out as described in Lehrach et ai,
(1977). Hybridizations with RNA on agarose gel were done
as described in Smiley et ai, (1983). Prehybridizations
were performed overnight at 42°C in a large volume of 5 x
SSC (lx SSC is 0.15 M NaCl, 15 mM sodium citrate pH
7.0), containing 50% formamide, 0.1% PVP, 0.1% Ficoll,
1 mM EDTA, 0.2% NaDodS04, and 100 u.g/ml of denatured
salmon sperm DNA. Hybridizations were performed over-
night at 42°C in 5 x SSC, containing 50% formamide, 0.1%
PVP, 0.1% Ficoll, 1 mMEDTA, 10% dextran sulfate, 0.2%
NaDodS04, and 100 u,g/ml of denatured salmon sperm
DNA. Washing was initially at 65°C with 2x SSC, 0.1%
NaDodS04, and then with 0.2 x SSCand0.1%NaDodSO4.
RESULTS
Production ofBVDV
Bovine embryonic kidney cells (BEK-1) and BVDV-Os-
loss strain were selected for virus production because of our
observation of the capacity of this cell-virus pair to produce
a high progeny titer (approximately 108 pfu/ml) under the
conditions described in Materials and Methods. Five pas-
sages of the virus on BEK-1 cells were required to achieve
amplification to this titer, but cytopafhic effects, consisting
of clustering of cells followed by vacuolation and cell lysis,
were readily observable from the first passage. Although
BVDV infections usually produced 90% lysis of the cell
monolayer, only partial recovery of infectious virus was ob-
tained from the medium. Freezing and thawing was neces-
sary to disrupt cells further formarginal recovery ofprogeny
virus with titers between 107 and 108 pfu/ml.
Characterization ofBVDV
Infectious virus had a density of 1.12 g/ml as measured by
isopycnic banding in a sucrose density gradient and appear-
ed as 45- to 55-nm diameter spherical particles by electron
microscopy (Fig. 1A, B). The virus preparations were neu-
tralized by several bovine anti-BVDV antisera, kindly pro-
vided to us by M. Lobman (RIT-Smith & Kline, Rixensart,
Belgium) and B. Lansival (Institut Provincial Vétérinaire,
Marloie, Belgium). Table 1 shows data from a typical virus
neutralization experiment performed with the Marloie anti-
serum. Complete neutralization could be obtained only with
relatively low dilution of the serum, but some neutralizing
activity was evident at dilutions as high as 1:500. From these
neutralization tests we conclude that the high-titer virus ob-
tained by passage of the biologically cloned Osloss BVDV
strain in BEK-1 cells is serologically indistinguishable from
BVDV field isolates.
Intracellular RNA synthesis during the infection
To investigate the properties of virus-specific RNA pre-
sent in the high-titer virus population, we monitored intra-
cellular RNA synthesis at intervals during BVDV infection.
BEK-1 cells were infected with BVDV at a multiplicity of
infection greater than 1. After 12, 15, 18, and 21 hr, newly
synthesized RNA was pulse-labeled with [3H]uridine for 30
min before extraction. As a control, uninfected BEK-1 cel-
lular RNA, identically pulse-labeled and harvested at 18 hr
followingmock infection ofcells, was also analyzed. Infect-
ed and uninfected cellular RNAs were fractionated on 0.9%
agarose gels. As shown in Fig. 2, at each postinfection period
analyzed, a virus-specific RNA band of approximately 12.5
kb, not present in uninfected cells, could be observed. No























































FIG. 1. A. Purification of BVD virus by isopycnic centrifugation. Two milliliters of concentrated virus (see Material and
Methods) were loaded on a linear sucrese gradient (15-45%). The sample was centrifuged 15 hr at 27,000 rpm in a Spinco SW28
rotor. Twenty one fractions were collected and individually titered for virus infectivity. B. Electron micrograph of purified BVDV
preparations. V, Typical virus particles; N, permeabilized virions with visible nucleocapsid; R, raquet forms.











Medium (100 u.1) containing 5 x 103 infectious virions was incubated
for 1 hr at 37°C with 100 u.1 of calf antiserum preabsorbed on BEK-1
uninfected cell extract. At the end of the incubation, the treated samples
were inoculated onto subconfluent BEK-1 cultures for plaque titration
assays.
Characterization of the viral RNA
To verify that the 12.5-kb RNA found exclusively in in-
fected cells was also associated with viral particles, we pel-
leted virions from infected cell lysates and purified total
RNA from these pellets as described in Materials and Meth-
ods. RNA obtained from pelleted virions was labeled at the
3'-terminus with [32P]-pCp and RNA ligase and analyzed by
agarose gel electrophoresis in the presence of 2.2 M formal-
dehyde (Fig. 3). Most of the radioactivity was associated with
low-molecular-weight RNA (<2 kb), but a high-molecular-
weight band of approximately 12.5 kb was consistently ob-
served. Its rapid labeling kinetics with RNA ligase provided
an initial indication that the 12.5-kb band was in fact RNA,
and not contaminating DNA derived from lysed cells. To
confirm this conclusion a sample was treated with either
RNase A or alkali before electrophoretic analysis. In both
cases the 12.5-kb band was completely eliminated. Treat-
ment with either DNase or Proteinase K did not affect the
migration properties of the 12.5-kb material (data not
shown).
As indicated in Fig. 3, the BVDV RNA band represents a
minor proportion of the total RNA extracted from virions. In
a first set of experiments, we attempted to enrich the genom-
ic viral RNA by chromatography on oligo(dT)-cellulose.
BVDV RNA failed to bind to the column and was quantita-
tively recovered in the flow-through fractions together with
the majority of the contaminating low-molecular-weight
RNA. The same result was obtained with pulse-labeled in-
tracellular viral RNA (data not shown).
As an alternative purification method, we then used su-
crose velocity gradient sedimentation to fractionate BVDV
genomic RNA. As shown in Fig. 4, the 12.5-kb RNA was
readily separated from smaller RNA species, yielding a final
pool of BVDV RNA estimated to be 50% pure. (This esti-
mate is based on the percentage of total incorporation of
labeled pCp present in BVDV 12.5-kb RNA.) The final pu-
rified BVDV RNA pools obtained from five sucrose gradi-
ents contained approximately 10 p,g of total RNA, or 5 u.g of
BVDV-specific RNA.
Preparation of BVDV-specific probes
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FIG. 2. Intracellular BVDV RNA synthesis. Newly synthe-
sized viral RNA, pulse-labeled with [3H]uridine, was analyzed
on 0.9% agarose gels in the presence of 2.2 M formaldehyde.
Lane M, E. coli 16S and 23S ribosomal RNA. Lanes 1-4, RNA
from infected cells at 12, 15, 18, and 21 hr after infection, re-
spectively. Lane C, Uninfected cell RNA at 18 hr.
FIG. 3. Agarose gel electrophoresis of viral RNA prepara-
tions. RNA isolated from a virus pellet was labeled with pCp
using RNA ligase and electrophoresed on a 0.9% agarose gel in
the presence of 2.2 M formaldehyde. Lane M contains labeled
18S and 28S ribosomal RNAs. Lanes 1 and 2 contain RNA from
a low ( 107 pfu/ml) and high-titer virus preparation ( 108 pfu/m 1 ),
respectively.
RNA samples were substantially contaminated with cellular
RNA, presumably random cellular sequences, i.e., ribo-
somal RNA, pelleted during the virus concentration step. To
prepare representative probes which would preferentially
hybridize to BVDV sequences (BVDV-specific cDNA),
random cDNA transcripts of sucrose gradient-purified
BVDV genomic RNA were synthesized. This cDNA was
first prehybridized to an excess of uninfected cellular RNA
and the resultant unfractionated RNA: cDNA mixture then
hybridized to a nitrocellulose filter on which uninfected
BEK-1 cell RNA, infected cell RNA, control yeast tRNA,
and template BVDV genomic RNA had been spotted.
The results of this experiment are presented in Fig. 5.
Some residual hybridization to uninfected RNA (dot 1)
could be detected but a visibly stronger signal was obtained
with infected cell RNA (dot 2 ) and template BVDV RNA
(dot 4). No hybridization was observed with the yeast tRNA
control (dot 3). The difference in signal obtained in the hy-
bridization to infected versus uninfected cells provided evi-
dence that our BVDV-specific probe was adequate for screen-
ing of a recombinant cDNA library. Virus-negative cDNA
probes (representative of total cellular RNA sequences) were
prepared by reverse transcription of total uninfected BEK-1
cell RNA.
Attempts to polyadenylate BVDV RNA
A specific priming site at the 3' terminus of the BVDV
RNA was desired for use during complementary DNA synthe-
sis and DNA cloning experiments. Our preliminary character-
ization of BVDV RNA using oligo(dT) binding suggested that




















































FIG. 4. Purification of BVDV RNA by centrifugation on sucrose gradients. The purification was carried out as described in
Materials and Methods. Lanes 2-16, Fraction number, top to bottom; the arrow indicates the position of 12.5-kb material.
these studies did not exclude the presence of a very short
oligo(A) tail, it seemed prudent to attempt the addition of
new A residues.
Polyadenylation reactions were carried out in the presence
of E. coli poly(A) polymerase in molar excess, using both
poliovirus RNA and ribosomal RNA as positive controls.
Polyadenylation reactions proceeded poorly under the stan-
dard conditions described by Sippel (1973); preincubation of
the RNA with 10 mM methylmercury hydroxide was found
to be essential for extensive polyadenylation with all of our
RNA samples. Under these conditions both control samples
and total BVDV RNA were efficiently labeled in vitro with
[3H]ATP; however, after displaying the RNAs on denatur-
ing agarose gels, no polyadenylation of the full-length 12.5-
kb BVDV RNA was detected by fluorography/autoradiogra-
phy (data not shown). Probably the 12.5-kb BVDV RNA is
susceptible to trace nucleases which do not affect poliovirus
RNA. Alternately, the 3' end of BVDV RNA may be inacces-
sible to the poly(A) polymerase (but available to RNA ligase).
Further experiments are necessary to resolve this issue.
Cloning of BVDV-specific cDNA sequences
Although we were unable to resolve some uncertainties
generated by the polyadenylation experiments we proceeded
to prepare cDNA libraries using oligo(dT) primers in the
synthetic step with in vitro polyadenylated BVDV RNA as
substrate (previously partially purified on sucrose gradients,
see Fig. 4).
Approximately 0.7 p,g of genomic BVDV RNA was used in
a single reaction under conditions selected to obtain optimal
cDNA elongation (see Materials and Methods). The resulting
cDNA:RNA hybrids were treated with RNase A to remove
free RNA and purified on a Sepharose 4BCL column to elimi-
nate relatively short hybrid molecules (<800 bp). Cloning in
E. coli was performed after tailing of the RNAxDNA hybrids
with dC and annealing to plasmid pBR322 tailed with dG at
the Pst I site.
Screening of the clones was performed on replicates with
either virus-negative or BVDV-specific (prehybridized as
above) 32P-labeled cDNAs as probe. Colonies which gave a
clear signal with the BVDV-specific probe but no response
with the virus-negative probe were selected. By this method,
95 positive clones from a library of 2900 clones were obtain-
ed. The length of the inserts in these clones as determined by
electrophoresis after Pst I digestion varied from approxi-
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FIG. 5. RNA dot blot hybridizations with a BVDV-specific
cDNA probe. One microgram of each indicated RNA sample
was spotted on a nitrocellulose strip which was then hybridized
with the BVDV-specific cDNA probe as described in the text.
Characterization ofBVDV-Specific cDNA clones
Our principal criteria for the initial identification of
BVDV genomic RNA were its size (12.5 kb), presence in
infected cells, and absence from uninfected cells. Thus,
clones derived from genomic BVDV RNA should (i) hybri-
dize back to infected cell RNA (but not uninfected cell
RNA), and (ii) similarly react with the 12.5-kb genomic
RNA band present exclusively in and isolated from infected
cells.
For this second step in the identification of recombinant
cDNA clones representing BVDV genomic sequences, we
subscreened a set of clones, designated pDT7, 17, 28, 32,
39, 40, 65, and 87. Each of these clones had given distinct
positive signals in the initial screening and were subsequently
shown to contain different size inserts by restriction
FIG. 6. RNA dot blot hybridizations with BVDV-specific
clones. Twenty nanograms of partially purified BVDV genom-
ic RNA (1), 4 u-g each of RNA isolated from BVDV-infected
BEK-1 cells (2), uninfected BEK-1 cells (3), BHK21 cells in-
fected with Sindbis virus (4), and 4 u.g of yeast tRNA (5) were
spotted on nitrocellulose strips which were then hybridized with
probes prepared from the inserts to plasmids pDT65, pDTH17
and pDT7, as described in Materials and Methods.
endonuclease analysis. Individual plasmid inserts were
labeled in vitro as described in Materials and Methods, and
hybridized to nitrocellulose strips spotted with control yeast
tRNA, Sindbis virus-infected BHK21 cell RNA, uninfected
BEK-1 cell RNA, BVDV-infected BEK-1 cell RNA, and
template BVDV RNA (isolated genome). The hybridization
observed was limited to BVDV-containing RNA samples
only, thus confirming the specificity of our screening proce-
dure; Fig. 6 shows three representative strips with inserts
from plasmids pDT7, 17, and 65 as probes.
To identify the RNA species in infected cells which hy-
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FIG. 7. RNA gel hybridization with BVDV-specific clones.
RNA gel hybridizations were performed according to Smiley et
ai (1983) with a probe prepared from plasmid pDT28 insert
DNA. Lanes 1 and 2 contained 10 |xg of RNA isolated from
uninfected and BVDV-infected BEK-1 cells, respectively, and
lane 3, 20 ng of partially purified BVDV genomic RNA.
FIG. 8. Southern blot of cellular genomic DNA with a
BVDV-specific clone. DNA (10 u,g) isolated from (uninfected)
BEK-1 cells was digested with Eco RI and electrophoresed on
1% agarose. The DNA was blotted onto nitrocellulose and the
blot hybridized with a probe prepared from a plasmid contain-
ing bovine growth hormone cDNA (lane bgh) or the insert from
pCT185 plasmid DNA (lane 185).
were performed. Fig.7 shows a typical result obtained with
the labeled insert from clone pDT28. Lane 1, containing
uninfected cell RNA, gave a completely blank pattern; lane
2, containing infected cell RNA, exhibits a faint band at 12.5
kb, while in lane 3, containing partially purified BVDV
genomic RNA, a distinct 12.5-kb RNA band is observed.
As a final control for the viral origin of the clones, we
hybridized pCT185, a clone from a separate cDNA library
overlapping pDT 40 (see Fig. 9, group 2, below) to bovine
genomic DNA. Since BVDV sequences are believed to be
unrelated to host cell DNA, no hybridization should be ob-
served with clones of viral origin; a bovine growth hormone
cDNA clone (Miller et ai, 1980) was used as a positive
control. As shown in Fig. 8, lane B, the viral cDNA clone
insert did not hybridize to bovine DNA, while the growth
hormone cDNA probe (lane A) identified a band of ~4 kb as
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FIG. 9. Mapping ofBVDV-specific clones. The five, nonoverlapping (designated 1-5) families were deduced from the hybridi-
zation experiments described in the text. The star indicates clones used as probes. Overlaps within families are approximate and
based on restriction mapping and hybridization intensities.
Mapping of BVDV-specific clones
To map the 95 pDT clones relative to one another, we
used Southern blots of Pst I-digested plasmid DNAs
fractionated on agarose gel. These blots were hybridized
with the eight probes described previously (labeled inserts
from plasmids pDT7, 17, 28, 32, 39,40, 65, and 87). These
hybridizations allowed us to classify the 95 clones into five
nonoverlapping families (Fig. 9) which account for at least 6
kb of the 12.5-kb BVDV genome. Some clones of the pDT
series did not react with any of the eight probes employed
and thus comprise additional portion(s) of the BVDV
genome outside the region represented by the five family
groups.
DISCUSSION
The molecular structure of BVDV has been difficult to
analyze due to the lack of a good in vitro virus production
system which yields adequate material for further study. In
this paper we describe a new cell-virus strain pair, Osloss
strain of BVDV and BEK-1 cells, which allowed us to
produce consistently virus at high titers (107 to 108 pfu/ml)
not previously reported (Horzinek, 1981). We have exclud-
ed the possibility that another contaminant virus has been
isolated because the virus described here was biologically
cloned and is completely neutralized by sera from BVDV
infected calves. In addition this virus exhibits all the
characteristics previously reported for BVDV: a small
enveloped virion diameter 45-55 nm) of density of 1.12
g/cm3 containing a single-stranded RNA genome of —12.5
kb (Horzinek, 1981).
Partial purification of sucrose gradients of the BVDV
RNA isolated from a virus pellet permitted an initial molecu-
lar characterization of the BVDV genome. Based on its
nonretention on an oligo(dT) column, the viral RNA appears
not to be polyadenylated. Also, no subgenomic-length viral
RNAs were detected in infected cells. It should be noted that
these properties (absence of polyadenylation and of sub-
genomic RNA species) have been reported previously for
other togaviruses, in particular fiaviviruses, (Schlesinger,
1980; Wengler and Wengler, 1981). Our results agree in
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the data of Purchio etal.(\983) who have reported an 8.2-kb
genomic RNA. This difference in the molecular weight of
the BVDV genome might be related to strain differences or
to the fact that these authors may have isolated a noncyto-
pathogenic strain of BVDV, which has been reported to be
present in the MDBK cells used for their study (Nuttall,
1978).
We have attempted to polyadenylate the purified genomic
RNA in vitro with ATP and E. coli poly (A) polymerase.
Whereas this technique worked well with control poliovirus
RNA and ribosomal RNAs, it did not proceed with intact
BVDV RNA as judged by (i) the absence of labeled BVDV
RNA band after the enzymatic reaction with labeled ATP,
(ii) the appearance of lower-molecular-weight products
which may indicate a degradation of the viral RNA during
the reaction, and (iii) the fact that the clones we obtained
after oligo(dT) priming of this putatively polyadenylated
RNA can be classified in different families covering dis-
persed parts of the genome indicative of random initiation.
In contrast, RNA ligase was successfully employed to 3'
label BVDV genomic RNA, but we have not investigated
the reasons for this difference in behavior between the
enzyme-catalyzed polyadenylation and pCp ligation
reactions; a possible explanation is the presence of a 3'-
phosphate which blocks poly(A) polymerase activity but not
RNA ligase (Krug and Uhlenbeck, 1982).
Finally and most importantly, we describe in this paper
the first successful molecular cloning of BVDV sequences.
Ninety-five virus-specific clones, containing BVDV se-
quences clustered in five, nonoverlapping families account-
ing for at least half the viral genome, were obtained. Identi-
fication of virus-specific clones relies on hybridization to the
genomic viral RNA present in infected cells and on the
absence of hybridization to either uninfected cellular RNA
or with Eco Rl-digested bovine genomic DNA. This suc-
cessful initial cloning should provide the route to a complete
molecular characterization of the BVDV genome and the
identification and expression of the virus-coded proteins.
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